Two weeks ago, the Food and Drug Administration (FDA) approved Vyleesi (bremelanotide), a first-in-class injectable treatment indicated for hypoactive sexual desire disorder (HSDD) in pre-menopausal ...

Pop culturally, female sexual desire is treated as the holy grail: oft-sought, oft-imitated, oft-worshipped and oft-misunderstood. But outside of Hollywood writers’ rooms, the holy grail does not ...

Ducharme is a contributor to TIME. Ducharme is a contributor to TIME. On June 21, the U.S. Food and Drug Administration (FDA) approved Vyleesi, a libido drug being hailed as the new “female Viagra.” ...

In the United States, two drugs have been approved to treat female sexual interest/arousal disorder (FSIAD): Vyleesi (bremelanotide) and Addyi (flibanserin). Some people may refer to these as “Viagra ...

Addyi and Vyleesi are medications for boosting sexual desire in women. Addyi is taken daily at bedtime, while Vyleesi is ...

Vyleesi is approved for the treatment of premenopausal women with acquired, generalized, hypoactive sexual desire disorder (HSDD) as characterized by low sexual desire that causes markeddistress or ...

What's up with headlines calling Vyleesi a "female Viagra"? Yes, both medications begin with the letter "V" and are designed to address sex-related health issues. But there are real hard differences ...

The First FDA-Approved As-Needed Treatment for Premenopausal Women Experiencing Low Sexual Desire and Associated Distress Now Available to Patients WALTHAM, Mass., Aug. 27, 2019 (GLOBE NEWSWIRE) -- ...

The RECONNECT Studies Demonstrated a Clinically Meaningful and Statistically Significant Improvement in the Co-Primary Endpoints of Desire and Associated Distress WALTHAM, Mass., Oct. 11, 2019 (GLOBE ...

Vyleesi (bremelanotide injection; AMAG Pharmaceuticals) is now commercially available through specialty pharmacies, Avella and BioPlus. Vyleesi (bremelanotide injection; AMAG Pharmaceuticals) is now ...